证券记录 · 已归档季度
PRME
Prime Medicine, Inc. · Healthcare · Biotechnology
18被追踪持有人
+3Δ持有人
30.74M持有股份
$170.29M报告持仓市值
+3新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +20.0% ·
股份流向 +30.0% ·
净新建仓位 +16.7%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +1 | 62.51M | $230.64M | +6 | −5 |
| Q1 2026 | 80 | +2 | 55.31M | $192.04M | +9 | −7 |
| Q4 2025 | 78 | 0 | 56.37M | $195.61M | +1 | −1 |
| Q3 2025 | 18 | +3 | 30.74M | $170.29M | +3 | — |
| Q2 2025 | 12 | +1 | 18.57M | $45.87M | +1 | — |
| Q1 2025 | 8 | 0 | 10.06M | $20.03M | +1 | −1 |
| Q4 2024 | 8 | -1 | 11.48M | $33.53M | +2 | −3 |
| Q3 2024 | 8 | -1 | 11.29M | $43.71M | +1 | −2 |
| Q2 2024 | 9 | — | 11.11M | $57.12M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | ARK Investment Management ✦ | 5.48M | +135.8% | $30.35M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 4.92M | +35.7% | $27.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 4.92M | +35.7% | $27.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 4.92M | +35.7% | $27.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 2.81M | -24.9% | $15.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 2.81M | -24.9% | $15.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 2.81M | -24.9% | $15.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 2.22M | 新增 | $12.28M | 0.0% | New | 1 | SEC ↗ |
| 17 | Geode Capital Management ✦ (被动) | 1.77M | +16.9% | $9.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Geode Capital Management ✦ (被动) | 1.77M | +16.9% | $9.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Millennium Management ✦ | 1.42M | +858.5% | $7.86M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (被动) | 1.30M | +4.6% | $7.18M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Renaissance Technologies ✦ | 1.13M | +407.9% | $6.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 900.14K | +72.6% | $4.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 900.14K | +72.6% | $4.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Adage Capital Partners ✦ | 771.36K | 新增 | $4.27M | 0.0% | New | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 447.67K | +73.2% | $2.48M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 414.21K | -2.4% | $2.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 414.21K | -2.4% | $2.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 414.21K | -2.4% | $2.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 414.21K | -2.4% | $2.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 410.74K | — | $2.28M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Goldman Sachs Group ✦ | 410.74K | — | $2.28M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Wellington Management ✦ | 205.32K | 新增 | $1.14M | 0.0% | New | 1 | SEC ↗ |
| 39 | Wellington Management ✦ | 205.32K | 新增 | $1.14M | 0.0% | New | 1 | SEC ↗ |
| 40 | Wellington Management ✦ | 205.32K | 新增 | $1.14M | 0.0% | New | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 86.78K | — | $480,750 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 86.78K | — | $480,750 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 86.78K | — | $480,750 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 86.78K | — | $480,750 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | T. Rowe Price ✦ | 74.50K | +14.1% | $413,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $12.28M | 0.0% |
| Adage Capital Partners | $4.27M | 0.0% |
| Wellington Management | $1.14M | 0.0% |
| Wellington Management | $1.14M | 0.0% |
| Wellington Management | $1.14M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 189 持有人, 97.53M 股份, $314.58M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据